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LEAVITr, F. I. Drug-induced modifications in sexual behavior and open field locomotion of male rats. PHYSIOL. BEHAV. 
4 (5) 677-683, 1969.---Several drugs were selected for sexual and open field behavioral testing, according to the following 
criteria: they are known synergists or antagonists of presumptive neurotransmitters; they modify behaviors thought to be 
related to sexual behavior; or they enjoy a popular reputation as aphrodisiacs in man. The drugs chosen were scopolamine, 
physostigmine, methamphetamine, cocaine, tranylcypromine, diazepam, cantharidin, and oxytocin. Scopolamine and 
diazcpam disrupted sexual behavior, despite having differential effects on open field locomotion; locomotion was increased 
by scopolamine and unchanged by diazep~tn. Cocaine and methamphetamine increased locomotion, and in low doses 
were the only drugs to accelerate sexual performance. High doses of cocaine also increased locomotion, but had 
predominantly inhibitory actions on sexual performance. The other drugs were without significant effects on either 
behavior. The results are interpreted as indicating that activation of adrenergic pathways facilitates the sexual perform- 
ance of male rats, and that alterations of cholinergic balance are disruptive. Open field activity modifications arc not 
correlated with changes in sexual behavior. 
Sexual behavior Open field locomotion Self-stimulation Adrenergic Cholinergic Aphrodisiacs Male rats 
SEwa~a. recent studies have been concerned with identifica- 
tion of  the neurotransmitters which mediate sexual behavior. 
Bignami [4] systematically investigated the effects upon male 
rats of  various antagonists of  the neurotransmitter acetyl- 
choline. All but adiphenine disrupted sexual behavior; the 
others, in order of decreasing potency, were scopolamine, 
benactyzine, atropine, and methylatropine. The central anti- 
cholinergic activities of the drugs follow the same pattern, 
with benactyzine differing from adiphenine only in that the 
latter does not penetrate the blood-brain barrier. The results 
confirm an earlier study by Soulairac [40], in which atropine 
disrupted the sexual behavior of  male rats. However, 
Bignarni's animals were used for 8 months, during which time 
they were tested with several different drugs. The procedure is 
questionable, since sexual behavior changes with both age and 
experience [21], and interactions between age and experi- 
mental conditions have been reported [21]. Thus, the tem- 
poral sequence in which the drugs were administered assumes 
considerable importance. Secondly, drug-induced behavioral 
changes often persist beyond a single test session, because of 
learning [41], placebo [16], or rebound [36] effects. Bignami's 
procedure is not entirely clear, but it appears that equivalent 
numbers of rats were tested with drug and with saline. Then 
a second drug was tested and the roles reversed for drugged 
and control subjects. The new controls might have differed 
from their comparison group simply because they alone had 
had prior exposure to the first drug. For example, rats which 
have previously been tested with chlorpromazine mount 
more frequently during saline sessions than rats previously 
tested with caffeine [41]. 
Bignami's rats did not have access to food or water during 
test sessions. This suggests a possible peripheral mechanism 
for the disruptive effects of anticholinergics; they inhibit 
salivary secretions, scopolamine more so than atropine, so 
that extreme dryness of  the mouth results [12]. The subse- 
quent discomfort might interfere with sexual responsiveness. 
Soulairac did not state her schedule of  drug treatments, so 
the criticisms raised against Bignami may also apply to her 
work. Other questionable aspects of her methodology relate 
primarily to establishment and maintenance of  stable 
behavioral patterns. Most researchers give the experimental 
males several preliminary tests prior to drug administration; 
the males are habituated to the sex arenas prior to introduc- 
tion of  the females; full receptivity of the females during test 
sessions is assured by first observing them with experienced 
non-experimental males; subjects are tested during the dark 
phase of a regulated day-night cycle [4]. Failure to men- 
tion any of these procedures is distressing, especially since 
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females were prepared with single injections (20-100 ~g) of 
estradiol benzoate, which Beach [2] has reported to be 
ineffective in inducing high levels of receptivity. 
For many of  the drugs employed, Soulairac administered 
the same dosage to all subjects, regardless of their body 
weight. Frequently only one dose level was investigated. 
She made no scoring distinction between mounts and intro- 
missions, a procedure which has since been criticized [3]. 
Finally, her level of significance, p = 0. l, is unacceptable by 
most current standards. 
Bignami investigated the effects of nicotine, and Soulairac 
those of  physostigmine. These drugs represent the other side 
of the cholinergic-anticholinergic coin. Nicotine had little 
effect upon copulatory behavior except at doses which pro- 
duce motor impairment. By contrast, 100 ~tg doses of 
physostigmine produced severe decrements in the sexual 
performance of  male rats. The latencies to ejaculation were 
prolonged, and the number of ejaculations per one-hour test 
decreased. 
Soulairac's work with adrenergic drugs [40] is not easily 
systematized. Norepinephrine and large doses of  epinephrine 
inhibited sexual behavior, whereas 50 ~g/kg of epinephrine 
increased ejaculatory frequency. Iproniazid (2.5 mg/100 g/day) 
had an initial potentiating effect, but after 5 days of contin- 
uous treatment sexual behavior was impaired or abolished in 
all rats. The behavior returned to pre-drug levels after 14 
days of continuous treatment. The response to amphet- 
amine was biphasic; doses of  2 mg/kg initially increased 
ejaculatory frequency while shortening postejaculation 
refractory periods, but sexual behavior was frequently dis- 
rupted during later administrations. Bignami [4], too, 
reported an acceleration of sexual behavior after small 
(0.5 mg/kg) doses of  amphetamine, but at 2 mg/kg changes 
were in the opposite direction from those described by 
Soulairac. Differences in route of administration (i.p. for 
Soulairac, s.c. for Bignami), or strain differences in suscepti- 
bility may account for the disparate results. 
Several of the drugs used in the present study modify 
cholinergic or adrenergic functioning. Three substances 
reputed to possess aphrodisiac properties, viz., cantharidin, 
cocaine, and methamphetamine, were also tested, as was the 
neurohypophyseal hormone oxytocin. The latter drug 
facilitates several aspects of sexual performance in male 
rabbits [24]. 
Administration of drugs in doses which affect locomotor 
activity or responsiveness to electrical stimulation of reward 
sites in the brain might be expected to induce changes in 
sexual performance. Therefore, some drugs were selected on 
the basis of  their ability to modify these behaviors. 
MATERIALS AND METHODS 
Subjects 
The male subjects used in this experiment were hooded 
rats of the Long-Evans strain, obtained from Simonsen's 
Laboratories, Inc., Gilroy, California. They were approxi- 
mately 70 days old and weighed 300 g at the start of the 
experiment. The females were 200 g albino rats of the 
Sprague-Dawley strain, supplied by Spartan Research 
Animals, Inc. of  Haslett, Michigan. The females were 
housed in group cages, the males individually. Food and 
water were available at all times. At least one week prior 
to their first screening test, all males were placed on a reversed 
12 hr on, 12 hr offlight cycle. All tests were conducted during 
the first 4 hr of the dark portion of the cycle, in a room illu- 
minated by a single 25 W bulb suspended from the ceiling. 
Eighty males were randomly assigned to l0 different 
groups of  8 rats each. Rats from this initial grouping which 
died during the course of the experiment were replaced. 
When replacement subjects died no further substitutions were 
made. Thus, the final N in the cantharidin group is 4 because 
replacements died. A single animal and its replacement in 
the physostigmine group died. 
Apparatus 
The arenas used for sex-testing were rectangular boxes 
measuring approximately 2 4 × 1 2 × 1 2  in. with clear glass 
front oanels. Food pellets were scattered along the floor and 
water was available through a drinking spout on the side of 
the cage. The presence of  food and water was a precautionary 
measure designed to minimize potentially disruptive effects 
due to drug-induced changes in hunger or thirst. Mounts, 
intromissions, and ejaculations were recorded on a Rustrak 
4-channel event recorder. Animals were also tested in a 
4 × 4 ft field with gray wooden sides 1 ft in height. A sheet 
of while oilcloth ruled into 16 1-ft squares comprised the 
floor of the cage. 
Procedure 
Females were brought into estrus by s.c. injections of 
0.1 mg of  estradiol benzoate followed 72 hr later by 1.0 mg 
of progesterone. The progesterone was administered 3 hr 
prior to testing. The receptivity of  the females was judged by 
placing them with experienced non-experimental males, and 
only fully receptive females were used. They were rested for 
a minimum of two weeks between mating tests. 
Males were given sexual experience by testing them at 
weekly intervals until they achieved two ejaculations within 
a test session for 3 consecutive weeks. The third session was 
preceded by injection of isotonic saline. 
Four males were tested simultaneously, 2 each under drug 
and saline conditions. After being injected, the animals were 
returned to their cages for a predetermined period of time 
that varied with each drug (see Table 1), then adapted to the 
testing arena for 5 min before the female was introduced. 
Behavior was recorded up to and including the first intro- 
mission following the second ejaculation. After the auto- 
genital grooming which typically follows copulation had 
subsided, the males were removed. Tests were also terminated 
if 1 hr elapsed without an ejaculation, or 90 min without 2. 
These time limits are considerably longer than have been 
used in most recent research, and they resulted in the inclusion 
of  many subjects of  only moderate sexual vigor. Thus, 
facilitatory drug effects were not likely to be masked because 
subjects were already performing at maximal levels. Such a 
possibility was offered by Bignami [4] to account for the 
small effects he obtained with amphetamine. 
The animals were given 8 tests of sexual performance 
followed by 4 10-min tests in the open field. The inter-trial 
interval was 1 wk for all tests. The open field tests were 
conducted at the same time of day and under the same 
conditions as the sex tests. Animals were placed in the corner 
of the field nearest to the experimenter, and a count was made 
of  the number of squares entered during the subsequent 
10-min period. The criterion for entry of  a square was that 
both forepaws were in it. 
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TABLE 1 
DRUGS USED IN THE PRESENT EXPERIMENT 
Drug Dosage as Time between 
salt, mg/kg injection and 
testing (min) 
Approximate latency and duration 
of action (min) 
Dosages used in study cited 
in previous column (mg/kg) 
scopolamine 0.3 and 0.9 20 
hydrobromide 
physostigmine 0.2 and 0.8 5 
salicylate 
methamphetarnine 0.75 and 2.25 5 
hydrochloride 
cocaine 10.0 and 30.0 20 
hydrochloride 
tranylcypromine 2.0 and 4.0 120 
diazepam 2.5 and 5.0 20 
synthetic 0.5 IU/kg and 5 
oxytocin 1.0 IU/kg 
cantharidin 0.67 20 
15 and 20, for disruption of sexual 
behavior in male rats [4] 
15 and unknown, for reduced rates of 
self-stimulation in male rats [20] 
immediately and 60, for increased self- 
stimulation in male rats [33] 
immediately and 30, for increased loco- 
motor activity of male mice [38] 
120 and 60, for increased self-stimula- 
tion in male rats [33] 
less than 24 and more than 48, for 
increased self-stimulation in rats [31 ] 
immediately and 30, for improvement in 
sexual performance of male rabbits [24] 
immediately for occurrence of pain in 
young boy; 30 for appearance of blebs 
on skin; several weeks for remission of 
all symptoms [6] 
0.1 and 0.5 








The following measures were recorded." Sexual Contact 
Latency (SCL)-- the time in sec from introduction of the 
female to the male's first mount, with or without intromission; 
Intromission Latency ( IL)-- the  time in see from introduction 
of  the female to the first successful intromission; Mount 
Frequency (MF) - - the  number of mounts without intro- 
mission within a given series (the term "series" refers to the 
sequence of  sexual behaviors which is terminated by an 
ejaculation); Intromission Frequency ( IF) - - the  number of 
intromissions within a given series; Interintromission Interval 
( I I I ) - - the  average interval in see between mounts with intro- 
mission in the same series; First Total Ejaculation Latency 
(ELi) - - the  time in sec from introduction of the female to the 
first ejaculation; Second Total Ejaculation Latency (ELs)--  
the time in see between the first and second ejaculations; 
Postejaculatory Interval (PEI)- - the  time in sec from one 
ejaculation to the first intromission of  the next series. 
The open field measure (OF) was number of squares entered 
per 10 min period. 
Schedules of Treatment 
Within a group, each male was tested at two dose levels 
with a single drug. The cantharidin subjects were initially 
tested at two dose levels, but all subjects which received 2.01 
mg/kg died shortly thereafter. The remaining subjects and 
the replacements were therefore tested only at the lower dose 
(0.67 mg/kg). For  each drug 2 rats were assigned to each of  
the following sequences of administration, where S =isotonic 
saline, H = h i g h e r  dose of  drug, and L= lower  dose: 1. 
S -L-S- -L-S-H-S-H.  2. S - H - S - H - S - L - S - L .  3. L - S - L - S -  
H - S - H - S .  4. H - S - H - S - L - S - L - S .  One group of 8 rats 
received only saline throughout the testing. 
For  the open field tests the sequences were abbreviated to: 
1. S - L - S - H .  2. S -H-S-L .  3. L - S - H - S .  4. H-S--L-S. 
Drug Preparations, Routes of Administration, and Dosages 
All drugs were injected i.p. The dosages correspond with 
those used by previous investigators to modify behavior in 
various ways (see Table 1). Table 1 also presents drug 
preparations, intervals between administration and testing, 
and approximate latencies and durations of action. On 
saline days the rats were weighed and then injected with the 
same volumes of  saline as they would have received of drug. 
Volumes injected never exceeded 1 cm 3. 
Analysis of Results 
There are many missing values under most drug treatments, 
as a result of  drug disruption of sexual behavior. Procedures 
for replacing missing values for analysis of variance are not 
appropriate for the purpose of this experiment. Therefore, 
the randomization test for matched pairs [37] was employed 
to evaluate differences between saline, low dose, and high 
dose, for all measures listed above. Significance tests were 
computed only when at least 6 animals under each condition 
successfully mated. Approximately 200 separate comparisons 
were made, of  which 10 would be expected to be significant 
at p =0.05 by chance alone. The data for the saline group 
were subjected to a trend analysis. 
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RESULTS 
Means of  the various behavioral measures were obtained 
for each animal under each condition of  testing; only those 
trials in which 2 ejaculations were achieved are included in 
the computations. The means of  these individual subject 
moans were then obtained, and are presented in Tables 2-6. 
The Tables are organized so that sexual latency measures are 
grouped together, as are rate and frequency measures. The 
tables also indicate open field locomotion scores. 
The results for each of  the groups are presented below. 
Each section commences with an indication of  the number of 
failures to mate under saline, lower dose, and higher dose 
condition, followed by a presentation of  significant differences 
between the conditions on the various indices of sexual 
behavior. Strong trends are noted when they are of special 
interest, as are instances when no tests of  significance were 
made because of  reduced Ns due to failures to mate. The 
open field data are then considered. Finally, mention is 
made of  obvious qualitative behavioral changes under any 
of the conditions. 
Scopolamine 
Rats in the scopolamine group underwent a total of 32 
saline trials. Of these, 4 were terminated because of failure 
to achieve 2 ejaculations within the prescribed time limit. 
By contrast, out of  16 tests each at 0.3 and 0.9 mg/kg, there 
were 12 and 13 failures, respectively. Since fewer than ½ of 
the animals copulated under drug conditions, no tests of  
significance were made. The only obvious trend was toward 
increased M F  during successful scopolamine trials. M F  was 
larger in series 2 than in series 1 with both doses of  scopo- 
lamine, a pattern which was not observed under any other 
conditions. 
During sex tests, most of the rats which were injected with 
scopolamine lay passively in a corner of the test arena for the 
duration of  the sessions. This behavior was in marked 
contrast to that observed in the open field, where they were 
significantly more active than on control days. 
Physostigmine 
The only 4 failures to mate in the physostigmine group 
were at 0.8 mg/kg, a dose which significantly increased SCL. 
The other latency measures--IL,  EL, and PEI- -were  also 
increased, although the difference did not reach significance 
in the case of  IL. However, the shortest PEIs were recorded 
after 0.2 mg/kg. 
The mean II I  was increased by physostigmine, significantly 
so for the series 2 comparison between 0.8 mg/kg and saline. 
Both doses reduced IF,  the effect reaching significance at 
0.8 mg/kg in series 1, and 0.2 mg/kg in the second series. All 
open field comparisons were significant; activity was highest 
during saline sessions and least following treatment with 
0.8 mg/kg. Rats treated with the high dose frequently 
salivated, and made continuous jaw (swallowing?) move- 
ments. They were very sluggish, frequently remaining 
motionless for the entire test session. 
Methamphetamine 
Two rats failed to mate on both occasions following 
administration of  2.25 mg]kg methampbetamine. All other 
trials of  this group were successfully completed. The pattern 
observed following nondisruptive doses of  methampbetamine 
was an acceleration of  sexual activity. Latency measures 
TABLE 2 
EFFECTS OF PHYSOSTIGMINE ON MALE RAT SEXUAL [~EHAVIOR 
AND OPEN FIELD LOCOMOTION 
Saline 0.2 mg/kg 0.8 mg/kg 
(N : 7) (N = 7) (N == 6) 
Sex Scores 
Failures to mate 0/28 0/14 4/14 
Latency Measures 
Median SCL 11.5 8.5 471.9b 
Median IL 23.5 119.6 487.1 
ELI 749.9 738.1 1150.8a, b 
EL~ 563.1 525.2 684.9 
PEI1 340.4 334.8 435.7 
PEI2 431.9 402.1 a 452.7b 
Rate Measures 
Illt 61.3 69.8 106.4 
Ills 49.5 89.4 67.3a 
Frequency measnres 
MFI 8.6 10.5 6.1 
MF2 3.5 4.1 3.4 
IF 1 9.3 8.0 6.4a 
IF 2 4.6 3.5a 6.1 
Open Field Scores 60.8 32.3a 9.3a, b 
The subscripts 1 and 2 refer to series 1 and 2. The N for each 
condition is the number of subjects which completed at least one 
successful sex test under that condition. The Ns for open field 
data include subjects which failed in the sex tests, and are equal 
to the saline Ns in all cases. Lower-case indicated p < 0,05, upper- 
case p _-< 0.01. a , A = d r u g  vs saline; b,B-~-low dose vs high 
dose. Times are given in sec. These conventions are followed in 
Tables 3--6. 
were all shortened by the drug, although only in the case of 
IL was the difference significant (saline vs 2.25 mg/kg). 
Higher doses of the drug significantly increased both M F  
and IF. The strongest effect of  methamphetarnine was on 
open field locomotion. 
Cocaine 
Rats in the cocaine group failed to mate 3 times during 
saline sessions, and once each at 10 and 30 mg/kg. The 
effects of  higher and lower doses of cocaine, for most of the 
indices of  sexual activity, were in opposite directions, At  
10 mg/kg, cocaine facilitated sexual behavior; HI, PEI, and 
EL in both series were shortened significantly. All  of  the 
changes but PEI~ were reversed at 30 mg/kg. The higher 
dose significantly increased MF. 
Unlike the changes in sexual behavior, there was no 
reversal of the cocaine effect on open field locomotion; 
activity was increased by both doses. 
Tranylcypromine 
There was a single failure to mate in the tranylcypromine 
group, that during a saline session. The only significant 
difference in sexual behavior or open field scores is that rats 
treated with 4.0 mg/kg had fewer intromissions in series 1 
than when given saline. 
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TABLE 3 
EF~crs OF M E ~ n ~ I - ~ r ~  ON MALE RAT SEXUAL BW~VIOR 
AND OPEN F~LD LOCOMffrION. S~ Txm.~ 2 FOR EXI~LANATION 
OF SYMeOts 
Saline 0.75mg/kg 2.25mg/kg 
(N-----8) (N~---8) ( N = 6 )  
Sex Scores 
Failures to mate 0/32 0/16 4/16 
Median SCL 11.9 8.2 7.2 
Median IL 89.1 12.1 9.2a 
EI.q 605.0 589.3 591.8 
EL, 594.1 709.8 612.9 
PEI1 396.6 359.9 365.3 
PEIs 464.6 409.7 417.4 
Rate Measures 
III1 64.0 67.8 51.9 
IIIz 51.2 51.6 51.1 
M'F1 4.9 3.9 11.4 
MFj 1.7 2.1 7.3a 
IF~ 8.7 8.2 12.6a, b 
IFs 4.7 4.9 5.5 
Open Field Scores 43.9 94.6 107.1a, b 
Diazepam 
Administration of diazcpam in the dose of 5.0 mg/kg 
disrupted sexual behavior in 13 of 16 tests. Four of 16 tests 
were unsuccessfully concluded at 2.5 mg/kg, and 3 of 32 
saline trials. Statistical comparisons were made only between 
saline and 2.5 mg/kg. The most dramatic effect was a very 
large increase in MF, especially marked in series I. Diazcpam 
had an unusual effect on intromissions; IF  was significantly 
TABLE 4 
E F ~ r s  oF CocArNE ON MAuz RAT SEXUAL BEHAVIOR AND 
OPEN FIELD LOCOMOTION. SF~ TXBLE 2 PeR EXP~NATION 
OF SYMBOLS 
-Saline 10.0 mg/kg 30.0 mg/kg 
(N = 8) (N = 8) (N = 8) 
Sex Scores 
Failures to mate 3/32 1/16 1/16 
Latency Measures 
Median SCL 16.0 31.0 30.0 
Median IL 67.7 70.2 275.0 
ELt 859.7 586.2a 1020.9B 
EL* 581.3 431.0A 616.9B 
PEI1 381.8 330.5a 408.0B 
PEI2 466.6 390.7A 452.7b 
Rate Measures 
l i l t  79.3 62.4a 90.4a, b 
Ilia 50.1 34.6 61.3A, n 
Frequency Measures 
MFI 10.4 7.6 21.3A, n 
MF~ 6.9 6.9 14.7n 
IFx 10.3 9.8 9.2 
IFj 5.5 5.3 5.0 
reduced in the first series, but increased, also sjt, nificantly, in 
series 2. The shift occurred in all rats tested. IL, IlI,  and 
PEI were all increased by diazepam. There was a non- 
sitmificant decrease in open field locomotion at 5.0 mg/kg. 
TABLE 5 
EFFECTS OF DIAZEPAM ON MALE RAT SEXUAL BEHAVIOR AND 
Ovt~ FIELD LOCOMOTION. S~  TABLE 2 FOR EXPLANATION 
OF SYMBOLS 
Saline 2.5 mg/kg 5.0 mg/kg 
( N = 8 )  ( N = 7 )  ( N = 2 )  
Sex Scores 
Failures to mate 3/32 4/16 13/16 
Latency Measures 
Median SCL 15.7 11.6 7.5 
Median IL 67.4 324.1A 437.4 
EL* 782.3 1473.1a 911.3 
EL, 765.4 960.8a 875.3 
PEI1 416.9 563.6a 373.6 
PEII 479.6 547.6a 512.5 
Rate Measures 
III1 67.7 108.3a 105.0 
IIIs 56.7 65.1 109.8 
Frequency Measures 
MF1 10.5 52.0A 37.0 
MFI 5.6 19.3a 46.8 
IF1 11.8 8.2a 8.0 
IF, 5.8 6.4A 5.5 
Open Field Scores 58.4 62.5 40.3 
TABLE 6 
gEXUAL BEHAVIOR AND OPEN FIELD BEHAVIOR OF MALE RATS 
TREATED WITH SALINE 
Saline 
(N = 8) 
Sex Scores 
Failures to mate 8/64 
Latency Measures 
MedianSCL 13.7 













Open Field Scores 46.6 75.1A 117.5A Open Field Scores 59.8 
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Cantharidin 
Eight of the cantharidin rats died during the course of  
testing, leaving only 4 animals which completed the 8 sexual 
behavior trials. Of the 16 trials each with saline and can- 
tharidin, there were 1 and 3 failures to mate, respectively. 
No discernible trends were observed in the data of the 4 
animals; on none of the indices were the differences between 
saline and cantharidin sessions in the same direction for all 
subjects. 
Oxytocin 
The failures to mate in this group were 7 of 32, 5 of 16, and 
4 of 16, for saline, 0.5 IU/kg, and 1.0 IU/kg respectively. 
There were no significant differences on any of the indices in 
this group, nor were there any apparent trends. 
Saline 
Eight of the saline trials resulted in failure to mate. The 
trials were organized into blocks of  two, and then trend 
analyses were run for each of the indices used. There were 
no significant trends. 
DISCUSSION 
Comparison o f  Present Study with Previous Research 
In spite of several methodological differences between the 
present experiment and earlier ones in which the same 
dependent and independent variables were studied, the results 
correspond welt. Scopolamine and physostigmine have 
previously been reported to inhibit sexual behavior [4, 40], 
and the trend here toward reduced latencies of sexual re- 
activity in methamphetamine-treated rats closely parallels the 
findings with amphetamine [4] .  Melin and Kihlstrom's 
report [24] of an improvement in the sexual performance of 
male rabbits injected with oxytocin was not confirmed, 
however. Differences in species, route of administration 
(i.v. vs i.p.), dosage (0.15-0.60 IU vs 0.5-1.0 IU/kg), or 
method of  measurement (ejaculation into artificial vagina vs 
testing with live female) may account for the discrepant 
results. 
The open field data are also compatible with the existent 
literature. Cocaine, methamphetamine, and scopolamine have 
been reported to increase locomotor activity [25, 27, 38], and 
diazepam and tranylcypromine to have little effect [23, 35]. 
The Neurotransmitters Involved in Sexual Behavior 
The cholinergic system. Both Bignami's data [4] and the 
present results suggest that anticholinergic drugs inhibit 
sexual behavior in male rats. Physostigmine, which promotes 
cholinergic functioning, has a similar effect. Perhaps all 
modifications of cholinergic functioning in rats interfere 
with sexual behavior. Bignami has proposed that a central 
mechanism is responsible. 
The adrenergic system. Cocaine and methamphetamine 
accelerated sexual performance, thus extending earlier 
observations with amphetamine and LSD [4]. All four are 
adrenergic drugs which have predominantly central effects. 
Epinephrine, which acts at peripheral as well as central 
adrenergic sites, also potentiates sexual behavior at some 
doses [40]. Tranylcypromine had no effects on either sexual 
performance or locomotion, a result which accords with the 
observation [32] that MAO inhibitors "produce little or no 
change in the apparent behavior or attitude of  laboratory 
animals". 
Work with adrenergic blockers and deplctors compleiuents 
the abovementioned findings. Chlorpromazine interferes 
with sexual behavior in male rats [41], and men treated with 
the antiadrenergic drugs guanethidene, thioridazinc, or 
chlorprothixene frequently report inability to cjaculate [10, 
19, 26]. The transient sympathomimetic effects which are 
occasionally seen with reserpine [28] may account for its 
short-term improvement of the sexual performance of male 
rats [39], whereas the sexual inhibition after chronic adminis- 
tration [13] would be consonant with its depletor action. 
Although the sites at which adrenergic drugs act to acceler- 
ate sexual behavior cannot be stated with certainty, several 
studies suggest that they are central. Thus, Hess [17] has 
elicited sympathetic responses such as piloerection, mydriasis, 
increased blood pressure, and facilitation of spinal reflexes 
from electrical stimulation of the posterior hypothalamus of 
unanesthetized cats; under different conditions, stimulation 
of the same structure in rats and squirrel monkeys has pro- 
duced erection, ejaculation, and actual copulation [8, 15]. 
Moreover, castration modifies concentrations of norepine- 
phrine and dopamine in the anterior hypothalamus of male 
rats [11], and increases turnover rate of brain norepinephrine 
[ I ] .  
SelJ:stimulation and Sexual Behavior 
Several investigators [5, 18, 29] have demonstrated a 
relationship between rate of bar pressing for electrical 
stimulation of positively reinforcing brain sites, and hunger 
and thirst drives. Self-stimulation rate also varies with phase 
of the estrus cycle in female rats, being maximal during the 
period of heat [34]. Olds [29] showed that for some hypo- 
thalamic probes, the self-stimulation rate of male rats declines 
after castration and can be restored by androgen replacement 
therapy. Similar findings have since been reported [7, 15]. 
Copulation has been induced in male rats by electrical 
stimulation of sites which also supported self-stimulation 
[7, 8]. Herberg [15] observed that seminal ejaculation often 
follows electrical stimulation of positively reinforcing sites 
in rats. 
Of the 4 drugs used in the present study which have been 
previously shown to augment self-stimulation rates, cocaine 
and methamphetamine both facilitated sexual behavior, 
tranylcypromine was without effect, and diazepam was 
inhibitory. Reference has been made to the inactivity of 
tranylcypromine with respect to most behaviors. Diazepam 
may prolong the latencies to intromission and ejaculation 
because it depresses spinal reflexes [35]; Hart [14] has shown 
that the mechanisms for intromission and ejaculation in rats 
are organized within the spinal cord. In many respects the 
diazepam-treated rats appeared highly motivated sexually; 
SCL was less than on control days, and MF was markedly 
elevated. 
Physostigmine depresses self-stimulation rates in rats [20], 
and is disruptive of sexual behavior. Scopolamine lowers 
current thresholds for maintenance of self-stimulation, but 
the results have been explained in  terms of the increased 
resistance to extinction which scopolamine confers, rather 
than to changes in the reinforcing value of  the stimulation 
per se [9]. 
There is additional pharmacological support for the notion 
that self-stimulation rate and sexual performance covary. 
Reserpine, chlorpromazine, and morphine "all depress rates 
of self-stimulation as well as mating behavior [13, 30, 36, 41]. 
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LSD was tested at 200 tzg [reported in 30] for its effects on 
self-stimulation; at this dose, which impairs sexual behavior 
[4], stimulation rate declined. 
The results of tests with stimulant drugs are especially 
suggestive. Neither strychnine nor nicotine potentiate sexual 
performance [4], but caffeine does [41]. It is interesting to 
note that the drugs are similarly aligned with respect to their 
effects on self-stimulation [30]. 
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